UnknownNot Applicable

Role of ROTEM and Platelet Indices in Thrombocytopenic Patients .

45 participantsStarted 2023-05-01

Plain-language summary

1. Investigate the role of thromboelastometry (ROTEM) parameters in the prediction of bleeding events in thrombocytopenic patients. 2. Interpretation of platelet indices in thrombocytopenic patients and detection of their role in prediction of bleeding in these patients . 3. Examine the correlations between ROTEM parameters, platelet indices in thrombocytopenic patients .

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with thrombocytopenia and normal coagulation results * Patients with and without significant bleeding events Exclusion Criteria: * patients with abnormal routine coagulation results (M3,liver diseases,........) * patients who had received blood transfusions in the last 5 days. * patients taking anticoagulant drugs or antiplatelet drugs .

What they're measuring

investigate the role of EXTEM in detection of bleeding risk in thrombocytopenic patients by using thromboelastometry (ROTEM) delta analyzer

Timeframe: baseline

investigate the role of FIBTEM ROTEM parameter in detection of bleeding risk in thrombocytopenic patients by using thromboelastometry (ROTEM) delta analyzer

Timeframe: baseline

Trial details

NCT IDNCT05850481

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-04-01

Contact for this trial

Shaimaa Abdelazeem saber Selim, Assist Lecturer

01006214247 Shaimaaselim95@gmail.com

View on ClinicalTrials.gov More Patients With Low Platelets Counts trials